{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:11:48Z","timestamp":1791173508302,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Science and Technology Fund of Guizhou Provincial Health Commission","award":["no. gzwkj2023-283"],"award-info":[{"award-number":["no. gzwkj2023-283"]}]},{"name":"the Science and Technology Fund of Guizhou Provincial Health Commission","award":["No.gzwkj2025-310"],"award-info":[{"award-number":["No.gzwkj2025-310"]}]},{"name":"the Technology and Science Bureau of Zunyi","award":["no. 2024-13"],"award-info":[{"award-number":["no. 2024-13"]}]},{"name":"the Technology and Science Bureau of Zunyi","award":["No. 2024-21"],"award-info":[{"award-number":["No. 2024-21"]}]},{"name":"the Department of Science and Technology of Guizhou Province","award":["No.Qiankehe Foundation-ZK[2023] General 485"],"award-info":[{"award-number":["No.Qiankehe Foundation-ZK[2023] General 485"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Nat"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00114-025-02063-2","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T11:31:39Z","timestamp":1771846299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Promoting mechanisms of papillary thyroid carcinoma by the LncRNA CASC2\/miR-193a-3p\/RBM24 axis"],"prefix":"10.1007","volume":"113","author":[{"given":"Dong","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"2063_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010204","author":"S Agarwal","year":"2021","unstructured":"Agarwal S, Bychkov A, Jung CK (2021) Emerging biomarkers in thyroid practice and research. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14010204","journal-title":"Cancers (Basel)"},{"key":"2063_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12409","author":"Z Ba","year":"2018","unstructured":"Ba Z, Gu L, Hao S, Wang X, Cheng Z, Nie G (2018) Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a. Cell Prolif. https:\/\/doi.org\/10.1111\/cpr.12409","journal-title":"Cell Prolif"},{"key":"2063_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104646","author":"M Carnazza","year":"2025","unstructured":"Carnazza M, Quaranto D, Desouza N, Moscatello AL, Garber D, Hemmerdinger S et al (2025) The current understanding of the molecular pathogenesis of papillary thyroid cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26104646","journal-title":"Int J Mol Sci"},{"key":"2063_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/md20070427","author":"S Carpi","year":"2022","unstructured":"Carpi S, Scoditti E, Polini B, Brogi S, Calderone V, Proksch P et al (2022) Pro-apoptotic activity of the marine sponge Dactylospongia elegans metabolites pelorol and 5-epi-ilimaquinone on human 501Mel melanoma cells. Mar Drugs. https:\/\/doi.org\/10.3390\/md20070427","journal-title":"Mar Drugs"},{"key":"2063_CR5","doi-asserted-by":"publisher","first-page":"11242","DOI":"10.18632\/oncotarget.3593","volume":"6","author":"V Costa","year":"2015","unstructured":"Costa V, Esposito R, Ziviello C, Sepe R, Bim LV, Cacciola NA et al (2015) New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinoma. Oncotarget 6:11242\u201351. https:\/\/doi.org\/10.18632\/oncotarget.3593","journal-title":"Oncotarget"},{"key":"2063_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-017-0614-1","volume":"36","author":"R He","year":"2017","unstructured":"He R, Liu P, Xie X, Zhou Y, Liao Q, Xiong W et al (2017) CircGFRA1 and GFRA1 act as CeRNAs in triple negative breast cancer by regulating miR-34a. J Exp Clin Cancer Res 36:145. https:\/\/doi.org\/10.1186\/s13046-017-0614-1","journal-title":"J Exp Clin Cancer Res"},{"key":"2063_CR7","doi-asserted-by":"publisher","first-page":"10380","DOI":"10.1002\/jcb.28322","volume":"120","author":"F Huang","year":"2019","unstructured":"Huang F, Zhang Q, Chen W, Zhang H, Lu G, Chen J et al (2019) Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT\/ERK1\/2 signaling pathway. J Cell Biochem 120:10380\u201310390. https:\/\/doi.org\/10.1002\/jcb.28322","journal-title":"J Cell Biochem"},{"key":"2063_CR8","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1007\/s13577-021-00607-y","volume":"34","author":"K Huang","year":"2021","unstructured":"Huang K, Lu Z, Li L, Peng G, Zhou W, Ye Q (2021) Construction of a CeRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC. Hum Cell 34:1830\u20131842. https:\/\/doi.org\/10.1007\/s13577-021-00607-y","journal-title":"Hum Cell"},{"key":"2063_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-1-0716-2505-7_10","volume":"2534","author":"F Islam","year":"2022","unstructured":"Islam F, Zhou Y, Lam AK (2022) Long non-coding RNAs profiling using microarray in papillary thyroid carcinoma. Methods Mol Biol 2534:135\u2013148. https:\/\/doi.org\/10.1007\/978-1-0716-2505-7_10","journal-title":"Methods Mol Biol"},{"key":"2063_CR10","doi-asserted-by":"publisher","first-page":"830","DOI":"10.3803\/EnM.2022.1636","volume":"37","author":"MJ Jeon","year":"2022","unstructured":"Jeon MJ, Haugen BR (2022) Preclinical models of follicular cell-derived thyroid cancer: an overview from cancer cell lines to mouse models. Endocrinol Metab (Seoul) 37:830\u2013838. https:\/\/doi.org\/10.3803\/EnM.2022.1636","journal-title":"Endocrinol Metab (Seoul)"},{"key":"2063_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.22074\/cellj.2022.8036","volume":"24","author":"L Kang","year":"2022","unstructured":"Kang L, Sun J, Liu J, Xu F, Zhu Q, Shi X (2022) Long non-coding RNA CASC2 functions as a tumor suppressor in colorectal cancer via modulating the miR-18a-5p\/BTG3 pathway. Cell J 24:665\u2013672. https:\/\/doi.org\/10.22074\/cellj.2022.8036","journal-title":"Cell J"},{"key":"2063_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/pore.2023.1611138","volume":"29","author":"T Khonrak","year":"2023","unstructured":"Khonrak T, Watcharadetwittaya S, Chamgramol Y, Intarawichian P, Deenonpoe R (2023) RET rearrangements are relevant to histopathologic subtypes and clinicopathological features in Thai papillary thyroid carcinoma patients. Pathol Oncol Res 29:1611138. https:\/\/doi.org\/10.3389\/pore.2023.1611138","journal-title":"Pathol Oncol Res"},{"key":"2063_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.gene.2015.05.046","volume":"569","author":"X Lan","year":"2015","unstructured":"Lan X, Zhang H, Wang Z, Dong W, Sun W, Shao L et al (2015) Genome-wide analysis of long noncoding RNA expression profile in papillary thyroid carcinoma. Gene 569:109\u2013117. https:\/\/doi.org\/10.1016\/j.gene.2015.05.046","journal-title":"Gene"},{"key":"2063_CR15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s12094-019-02223-7","volume":"22","author":"QY Li","year":"2020","unstructured":"Li QY, Yang K, Liu FG, Sun XG, Chen L, Xiu H et al (2020) Long noncoding RNA CASC2c inhibited cell proliferation in hepatocellular carcinoma by inactivated ERK1\/2 and Wnt\/\u03b2-catenin signaling pathway. Clin Transl Oncol 22:302\u2013310. https:\/\/doi.org\/10.1007\/s12094-019-02223-7","journal-title":"Clin Transl Oncol"},{"key":"2063_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ncrna.2022.12.002","volume":"8","author":"K Li","year":"2023","unstructured":"Li K, Yao T, Wang Z (2023) LncRNA-mediated CeRNA network in bladder cancer. Noncoding RNA Res 8:135\u2013145. https:\/\/doi.org\/10.1016\/j.ncrna.2022.12.002","journal-title":"Noncoding RNA Res"},{"key":"2063_CR16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12020-019-01939-4","volume":"65","author":"M Liang","year":"2019","unstructured":"Liang M, Jia J, Chen L, Wei B, Guan Q, Ding Z et al (2019) LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p\/SPARC axis in papillary thyroid cancer. Endocrine 65:318\u2013326. https:\/\/doi.org\/10.1007\/s12020-019-01939-4","journal-title":"Endocrine"},{"key":"2063_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317711951","volume":"39","author":"L Liu","year":"2017","unstructured":"Liu L, Li Y, Liu S, Duan Q, Chen L, Wu T et al (2017) Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN. Tumour Biol 39:1010428317711951. https:\/\/doi.org\/10.1177\/1010428317711951","journal-title":"Tumour Biol"},{"key":"2063_CR18","first-page":"1361","volume":"14","author":"T Ma","year":"2022","unstructured":"Ma T, Li H, Yang W, Liu Q, Yan H (2022) Over-expression of miR-193a-3p regulates the apoptosis of colorectal cancer cells by targeting PAK3. Am J Transl Res 14:1361\u20131375","journal-title":"Am J Transl Res"},{"key":"2063_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.gene.2015.12.060","volume":"579","author":"F Meng","year":"2016","unstructured":"Meng F, Qian L, Lv L, Ding B, Zhou G, Cheng X et al (2016) MiR-193a-3p regulation of chemoradiation resistance in oesophageal cancer cells via the PSEN1 gene. Gene 579:139\u2013145. https:\/\/doi.org\/10.1016\/j.gene.2015.12.060","journal-title":"Gene"},{"key":"2063_CR20","doi-asserted-by":"publisher","first-page":"58606","DOI":"10.18632\/oncotarget.9686","volume":"7","author":"L Micolucci","year":"2016","unstructured":"Micolucci L, Akhtar MM, Olivieri F, Rippo MR, Procopio AD (2016) Diagnostic value of MicroRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis. Oncotarget 7:58606\u201358637. https:\/\/doi.org\/10.18632\/oncotarget.9686","journal-title":"Oncotarget"},{"key":"2063_CR21","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/mc.22826","volume":"57","author":"Y Pan","year":"2018","unstructured":"Pan Y, Hu J, Ma J, Qi X, Zhou H, Miao X et al (2018) MiR-193a-3p and miR-224 mediate renal cell carcinoma progression by targeting alpha-2,3-sialyltransferase IV and the phosphatidylinositol 3 kinase\/Akt pathway. Mol Carcinog 57:1067\u20131077. https:\/\/doi.org\/10.1002\/mc.22826","journal-title":"Mol Carcinog"},{"key":"2063_CR22","doi-asserted-by":"publisher","first-page":"728","DOI":"10.4103\/ijc.IJC_1365_20","volume":"61","author":"S Peng","year":"2024","unstructured":"Peng S, Yang Q, Pan Y, Li H, Wang J, Hu P et al (2024) Expression of the long noncoding RNA CASC2 in acute myeloid leukemia and its prognostic significance. Indian J Cancer 61:728\u2013735. https:\/\/doi.org\/10.4103\/ijc.IJC_1365_20","journal-title":"Indian J Cancer"},{"key":"2063_CR23","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.21037\/tau-21-226","volume":"10","author":"Q Ping","year":"2021","unstructured":"Ping Q, Shi Y, Yang M, Li H, Zhong Y, Li J et al (2021) Lncrna DANCR regulates lymphatic metastasis of bladder cancer via the miR-335\/VEGF-C axis. Transl Androl Urol 10:1743\u20131753. https:\/\/doi.org\/10.21037\/tau-21-226","journal-title":"Transl Androl Urol"},{"key":"2063_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00102","volume":"11","author":"A Prete","year":"2020","unstructured":"Prete A, Borges De Souza P, Censi S, Muzza M, Nucci N, Sponziello M (2020) Update on fundamental mechanisms of thyroid cancer. Front Endocrinol (Lausanne) 11:102. https:\/\/doi.org\/10.3389\/fendo.2020.00102","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2063_CR25","doi-asserted-by":"publisher","first-page":"410","DOI":"10.23736\/s0031-0808.21.04460-8","volume":"65","author":"F Qian","year":"2023","unstructured":"Qian F, Zhong M, Wu W, Li Y, Yuan H (2023) Establishment and verification of CeRNA network analysis and prognostic evaluation model for breast cancer. Panminerva Med 65:410\u2013411. https:\/\/doi.org\/10.23736\/s0031-0808.21.04460-8","journal-title":"Panminerva Med"},{"key":"2063_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3233\/cbm-181758","volume":"24","author":"I Reyes","year":"2019","unstructured":"Reyes I, Reyes N, Suriano R, Iacob C, Suslina N, Policastro A et al (2019) Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma. Cancer Biomark 24:71\u201383. https:\/\/doi.org\/10.3233\/cbm-181758","journal-title":"Cancer Biomark"},{"key":"2063_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP (2011) A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146:353\u20138. https:\/\/doi.org\/10.1016\/j.cell.2011.07.014","journal-title":"Cell"},{"key":"2063_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/genes11040424","author":"M Santoro","year":"2020","unstructured":"Santoro M, Moccia M, Federico G, Carlomagno F (2020) RET gene fusions in malignancies of the thyroid and other tissues. Genes. https:\/\/doi.org\/10.3390\/genes11040424","journal-title":"Genes"},{"key":"2063_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14071843","author":"DL Shi","year":"2022","unstructured":"Shi DL (2022) RBM24 in the post-transcriptional regulation of cancer progression: anti-tumor or pro-tumor activity? Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14071843","journal-title":"Cancers (Basel)"},{"key":"2063_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10\u201329. https:\/\/doi.org\/10.3322\/caac.20138","journal-title":"CA Cancer J Clin"},{"key":"2063_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"key":"2063_CR32","doi-asserted-by":"publisher","first-page":"10003","DOI":"10.26355\/eurrev_202010_23214","volume":"24","author":"Y Sun","year":"2020","unstructured":"Sun Y, Dai WR, Xia N (2020) Comprehensive analysis of lncRNA-mediated CeRNA network in papillary thyroid cancer. Eur Rev Med Pharmacol Sci 24:10003\u201310014. https:\/\/doi.org\/10.26355\/eurrev_202010_23214","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2063_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/7183629","volume":"2020","author":"L Tao","year":"2020","unstructured":"Tao L, Tian P, Yang L, Guo X (2020) lncRNA CASC2 enhances (131)I sensitivity in papillary thyroid cancer by sponging miR-155. BioMed Res Int 2020:7183629. https:\/\/doi.org\/10.1155\/2020\/7183629","journal-title":"BioMed Res Int"},{"key":"2063_CR34","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1248\/cpb.35.3699","volume":"35","author":"M Tominaga","year":"1987","unstructured":"Tominaga M, Ogawa H, Yo E, Yamashita S, Yabuuchi Y, Nakagawa K (1987) Studies on positive inotropic agents. IV. Synthesis of 5-(3-amino-2-hydroxypropoxy)-3,4-dihydro-8-hydroxy-2(1H)-quinolinone derivatives. Chem Pharm Bull (Tokyo) 35:3699\u20133704. https:\/\/doi.org\/10.1248\/cpb.35.3699","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"2063_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2244515","volume":"55","author":"B Wang","year":"2023","unstructured":"Wang B, Shen W, Yan L, Li X, Zhang L, Zhao S et al (2023) Reveal the potential molecular mechanism of circRNA regulating immune-related mRNA through sponge miRNA in the occurrence and immune regulation of papillary thyroid cancer. Ann Med 55:2244515. https:\/\/doi.org\/10.1080\/07853890.2023.2244515","journal-title":"Ann Med"},{"key":"2063_CR36","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrc3431","volume":"13","author":"M Xing","year":"2013","unstructured":"Xing M (2013) Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer 13:184\u2013199. https:\/\/doi.org\/10.1038\/nrc3431","journal-title":"Nat Rev Cancer"},{"key":"2063_CR37","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.biopha.2017.06.063","volume":"93","author":"X Xiong","year":"2017","unstructured":"Xiong X, Zhu H, Chen X (2017) Low expression of long noncoding RNA CASC2 indicates a poor prognosis and promotes tumorigenesis in thyroid carcinoma. Biomed Pharmacother 93:391\u2013397. https:\/\/doi.org\/10.1016\/j.biopha.2017.06.063","journal-title":"Biomed Pharmacother"},{"key":"2063_CR38","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12935-020-01507-1","volume":"20","author":"Y Xu","year":"2020","unstructured":"Xu Y, Huang X, Ye W, Zhang Y, Li C, Bai P et al (2020) Comprehensive analysis of key genes associated with CeRNA networks in nasopharyngeal carcinoma based on bioinformatics analysis. Cancer Cell Int 20:408. https:\/\/doi.org\/10.1186\/s12935-020-01507-1","journal-title":"Cancer Cell Int"},{"key":"2063_CR39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s13577-020-00458-z","volume":"34","author":"J Xue","year":"2021","unstructured":"Xue J, Xiao P, Yu X, Zhang X (2021) A positive feedback loop between AlkB homolog 5 and miR-193a-3p promotes growth and metastasis in esophageal squamous cell carcinoma. Hum Cell 34:502\u2013514. https:\/\/doi.org\/10.1007\/s13577-020-00458-z","journal-title":"Hum Cell"},{"key":"2063_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1089\/cbr.2021.0016","volume":"38","author":"G Yang","year":"2023","unstructured":"Yang G, Xu Q, Wan Y, Zhang L, Wang Z, Meng F (2023) miR-193a-3p enhanced the chemosensitivity to Trametinib in gallbladder carcinoma by targeting KRAS and downregulating ERK signaling. Cancer Biother Radiopharm 38:371\u2013379. https:\/\/doi.org\/10.1089\/cbr.2021.0016","journal-title":"Cancer Biother Radiopharm"},{"key":"2063_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12526","volume":"52","author":"HM Yu","year":"2019","unstructured":"Yu HM, Wang C, Yuan Z, Chen GL, Ye T, Yang BW (2019) LncRNA NEAT1 promotes the tumorigenesis of colorectal cancer by sponging miR-193a-3p. Cell Prolif 52:e12526. https:\/\/doi.org\/10.1111\/cpr.12526","journal-title":"Cell Prolif"},{"key":"2063_CR42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13046-018-0921-1","volume":"37","author":"Y Zhan","year":"2018","unstructured":"Zhan Y, Chen Z, Li Y, He A, He S, Gong Y et al (2018) Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149\/MSI2 axis as a CeRNA. J Exp Clin Cancer Res 37:273. https:\/\/doi.org\/10.1186\/s13046-018-0921-1","journal-title":"J Exp Clin Cancer Res"},{"key":"2063_CR43","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1158\/0008-5472.Can-17-2457","volume":"78","author":"J Zhang","year":"2018","unstructured":"Zhang J, Xu E, Ren C, Yang HJ, Zhang Y, Sun W et al (2018a) Genetic ablation of Rbm38 promotes lymphomagenesis in the context of mutant p53 by downregulating PTEN. Cancer Res 78:1511\u20131521. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-2457","journal-title":"Cancer Res"},{"key":"2063_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.22154","author":"S Zhang","year":"2018","unstructured":"Zhang S, Wang W, Zhao H, He F, Zhong K, Yuan S et al (2018b) Status of internal quality control for thyroid hormones immunoassays from 2011 to 2016 in China. J Clin Lab Anal. https:\/\/doi.org\/10.1002\/jcla.22154","journal-title":"J Clin Lab Anal"},{"key":"2063_CR45","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12943-018-0827-8","volume":"17","author":"Y Zhong","year":"2018","unstructured":"Zhong Y, Du Y, Yang X, Mo Y, Fan C, Xiong F et al (2018) Circular RNAs function as CeRNAs to regulate and control human cancer progression. Mol Cancer 17:79. https:\/\/doi.org\/10.1186\/s12943-018-0827-8","journal-title":"Mol Cancer"},{"key":"2063_CR46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3233\/cbm-181198","volume":"23","author":"T Zhou","year":"2018","unstructured":"Zhou T, Zhong M, Zhang S, Wang Z, Xie R, Xiong C et al (2018) LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway. Cancer Biomark 23:185\u2013191. https:\/\/doi.org\/10.3233\/cbm-181198","journal-title":"Cancer Biomark"}],"container-title":["The Science of Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00114-025-02063-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00114-025-02063-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00114-025-02063-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T08:04:51Z","timestamp":1778054691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00114-025-02063-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2063"],"URL":"https:\/\/doi.org\/10.1007\/s00114-025-02063-2","relation":{},"ISSN":["0028-1042","1432-1904"],"issn-type":[{"value":"0028-1042","type":"print"},{"value":"1432-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involving human samples and animal experiments was approved by the Ethics Committee of the Third Affiliated Hospital of Zunyi Medical University (Zunyilunshen [2022] 1-198). The procedures used in this study adhere to the tenets of the Declaration of Helsinki. All participants provided written consent. All experimental procedures were conducted in strict accordance with relevant guidelines and regulations to minimize animal suffering.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}